个人投资者慎入此股。

2017-12-28

$Editas Medicine, Inc.(EDIT)$ 主营业务很新！很高！很尖端！

but，

重点来了！医药股一般什么时候出现大涨？新的抗病物质出现的时候！更容易出现大涨是什么时候？

划重点：

新药通过三期临床验证并且拿到医药管理部门许可的时候！

换言之，一旦前期大量投资，结果三期临床试验表明效果并不理想，或存在一定程度的负面或不确定影响，一个大型医药公司，无非就是利润下滑，股价下跌，但是换一个没有其他盈利渠道的小型医药企业，作为投资者，你敢保证你能及时收手，不至于血本无归？你要是有那个自信，也有承担最终可能的巨大风险的能力，建议多标的，小投资额，勤关注。至于其他，祝你好运。

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

小米的韭菜1号
2018-03-02
小米的韭菜1号
反正这股现在我亏了
- 小米的韭菜1号:
  又赚回来了，哈哈
- konya:
  医药股由于行业的特殊性，对于曲线的理解在此类股票上，基本不适用，对政策性因素的敏感度却要高得多。尤其基因相关药物，在美国食药监管局（FDA）新药申请审批流程（NDA）的过程中，极易出现道德伦理障碍，无法被公众从心理上广泛接受的情况。这基本是现今医药行业股票投资最无法判断的影响因素。
lesen
2018-01-05
lesen
赚了30个点的路过……😂
- konya:
  三期临床出来的时候涨的挺厉害的，但个人不建议普通投资者出于理财目的碰医药股。
阿里巴巴死多头
2018-01-03
阿里巴巴死多头
你真正懂的话就不会说这个话了
- konya:
  哪个话呢？求指教。而且在这里说一个挺重要的事情，大型药企真正牛逼的地方，是自己的渠道，和相当数量能力出众的医药代表。至于企业规模随之形成的量产能力和成本控制能力，再次不多做论述。
赵大侠啊
2018-01-03
赵大侠啊
给你点赞

发表看法

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":138095,"tweetId":"138095","gmtCreate":1514472503343,"gmtModify":1704886587449,"author":{"id":3475415022952531,"idStr":"3475415022952531","authorId":3475415022952531,"authorIdStr":"3475415022952531","name":"konya","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":85,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"title":"个人投资者慎入此股。","extraTitle":"","html":"<html><head></head><body>$Editas Medicine, Inc.(EDIT)$ 主营业务很新！很高！很尖端！ but， 重点来了！医药股一般什么时候出现大涨？新的抗病物质出现的时候！更容易出现大涨是什么时候？ 划重点： 新药通过三期临床验证并且拿到医药管理部门许可的时候！ 换言之，一旦前期大量投资，结果三期临床试验表明效果并不理想，或存在一定程度的负面或不确定影响，一个大型医药公司，无非就是利润下滑，股价下跌，但是换一个没有其他盈利渠道的小型医药企业，作为投资者，你敢保证你能及时收手，不至于血本无归？你要是有那个自信，也有承担最终可能的巨大风险的能力，建议多标的，小投资额，勤关注。至于其他，祝你好运。 </body></html>","htmlText":"<html><head></head><body>$Editas Medicine, Inc.(EDIT)$ 主营业务很新！很高！很尖端！ but， 重点来了！医药股一般什么时候出现大涨？新的抗病物质出现的时候！更容易出现大涨是什么时候？ 划重点： 新药通过三期临床验证并且拿到医药管理部门许可的时候！ 换言之，一旦前期大量投资，结果三期临床试验表明效果并不理想，或存在一定程度的负面或不确定影响，一个大型医药公司，无非就是利润下滑，股价下跌，但是换一个没有其他盈利渠道的小型医药企业，作为投资者，你敢保证你能及时收手，不至于血本无归？你要是有那个自信，也有承担最终可能的巨大风险的能力，建议多标的，小投资额，勤关注。至于其他，祝你好运。 </body></html>","text":"$Editas Medicine, Inc.(EDIT)$ 主营业务很新！很高！很尖端！ but， 重点来了！医药股一般什么时候出现大涨？新的抗病物质出现的时候！更容易出现大涨是什么时候？ 划重点： 新药通过三期临床验证并且拿到医药管理部门许可的时候！ 换言之，一旦前期大量投资，结果三期临床试验表明效果并不理想，或存在一定程度的负面或不确定影响，一个大型医药公司，无非就是利润下滑，股价下跌，但是换一个没有其他盈利渠道的小型医药企业，作为投资者，你敢保证你能及时收手，不至于血本无归？你要是有那个自信，也有承担最终可能的巨大风险的能力，建议多标的，小投资额，勤关注。至于其他，祝你好运。","highlighted":1,"essential":1,"paper":2,"likeSize":0,"commentSize":8,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/138095","repostId":0,"isVote":1,"tweetType":1,"viewCount":1843,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["EDIT"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":514,"xxTargetLangEnum":"ZH_CN"},"commentList":[{"id":662389,"commentId":"662389","gmtCreate":1519999858644,"gmtModify":1519999858644,"authorId":3469164281621359,"author":{"id":3469164281621359,"idStr":"3469164281621359","authorId":3469164281621359,"name":"小米的韭菜1号","avatar":"https://static.tigerbbs.com/5b8820b392028ef580ce3c3a04f35605","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":138095,"objectIdStr":"138095","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"反正这股现在我亏了","text":"反正这股现在我亏了","html":"反正这股现在我亏了","likeSize":0,"commentSize":2,"subComments":[{"id":667360,"commentId":"667360","gmtCreate":1520469504263,"gmtModify":1520469504263,"authorId":3469164281621359,"author":{"id":3469164281621359,"idStr":"3469164281621359","authorId":3469164281621359,"name":"小米的韭菜1号","avatar":"https://static.tigerbbs.com/5b8820b392028ef580ce3c3a04f35605","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":138095,"objectIdStr":"138095","type":1,"supId":662389,"supIdStr":"662389","prevId":0,"prevIdStr":"0","content":"又赚回来了，哈哈","text":"又赚回来了，哈哈","html":"又赚回来了，哈哈"},{"id":662976,"commentId":"662976","gmtCreate":1520040272074,"gmtModify":1520040272074,"authorId":3475415022952531,"author":{"id":3475415022952531,"idStr":"3475415022952531","authorId":3475415022952531,"name":"konya","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":138095,"objectIdStr":"138095","type":1,"supId":662389,"supIdStr":"662389","prevId":0,"prevIdStr":"0","content":"医药股由于行业的特殊性，对于曲线的理解在此类股票上，基本不适用，对政策性因素的敏感度却要高得多。尤其基因相关药物，在美国食药监管局（FDA）新药申请审批流程（NDA）的过程中，极易出现道德伦理障碍，无法被公众从心理上广泛接受的情况。这基本是现今医药行业股票投资最无法判断的影响因素。","text":"医药股由于行业的特殊性，对于曲线的理解在此类股票上，基本不适用，对政策性因素的敏感度却要高得多。尤其基因相关药物，在美国食药监管局（FDA）新药申请审批流程（NDA）的过程中，极易出现道德伦理障碍，无法被公众从心理上广泛接受的情况。这基本是现今医药行业股票投资最无法判断的影响因素。","html":"医药股由于行业的特殊性，对于曲线的理解在此类股票上，基本不适用，对政策性因素的敏感度却要高得多。尤其基因相关药物，在美国食药监管局（FDA）新药申请审批流程（NDA）的过程中，极易出现道德伦理障碍，无法被公众从心理上广泛接受的情况。这基本是现今医药行业股票投资最无法判断的影响因素。"}],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0},{"id":590657,"commentId":"590657","gmtCreate":1515129681997,"gmtModify":1515129681997,"authorId":3459795204262974,"author":{"id":3459795204262974,"idStr":"3459795204262974","authorId":3459795204262974,"name":"lesen","avatar":"https://static.laohu8.com/25775e89762fe34a273a93179eefed79","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":138095,"objectIdStr":"138095","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"赚了30个点的路过……😂","text":"赚了30个点的路过……😂","html":"赚了30个点的路过……😂","likeSize":0,"commentSize":1,"subComments":[{"id":591546,"commentId":"591546","gmtCreate":1515158973281,"gmtModify":1515158973281,"authorId":3475415022952531,"author":{"id":3475415022952531,"idStr":"3475415022952531","authorId":3475415022952531,"name":"konya","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":138095,"objectIdStr":"138095","type":1,"supId":590657,"supIdStr":"590657","prevId":0,"prevIdStr":"0","content":"三期临床出来的时候涨的挺厉害的，但个人不建议普通投资者出于理财目的碰医药股。","text":"三期临床出来的时候涨的挺厉害的，但个人不建议普通投资者出于理财目的碰医药股。","html":"三期临床出来的时候涨的挺厉害的，但个人不建议普通投资者出于理财目的碰医药股。"}],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0},{"id":587408,"commentId":"587408","gmtCreate":1514986639882,"gmtModify":1514986639882,"authorId":3456416833532168,"author":{"id":3456416833532168,"idStr":"3456416833532168","authorId":3456416833532168,"name":"阿里巴巴死多头","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":138095,"objectIdStr":"138095","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"你真正懂的话就不会说这个话了","text":"你真正懂的话就不会说这个话了","html":"你真正懂的话就不会说这个话了","likeSize":0,"commentSize":1,"subComments":[{"id":587650,"commentId":"587650","gmtCreate":1514991795577,"gmtModify":1514991795577,"authorId":3475415022952531,"author":{"id":3475415022952531,"idStr":"3475415022952531","authorId":3475415022952531,"name":"konya","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":138095,"objectIdStr":"138095","type":1,"supId":587408,"supIdStr":"587408","prevId":0,"prevIdStr":"0","content":"哪个话呢？求指教。而且在这里说一个挺重要的事情，大型药企真正牛逼的地方，是自己的渠道，和相当数量能力出众的医药代表。至于企业规模随之形成的量产能力和成本控制能力，再次不多做论述。","text":"哪个话呢？求指教。而且在这里说一个挺重要的事情，大型药企真正牛逼的地方，是自己的渠道，和相当数量能力出众的医药代表。至于企业规模随之形成的量产能力和成本控制能力，再次不多做论述。","html":"哪个话呢？求指教。而且在这里说一个挺重要的事情，大型药企真正牛逼的地方，是自己的渠道，和相当数量能力出众的医药代表。至于企业规模随之形成的量产能力和成本控制能力，再次不多做论述。"}],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0},{"id":586315,"commentId":"586315","gmtCreate":1514911386888,"gmtModify":1514911386888,"authorId":3446384531735984,"author":{"id":3446384531735984,"idStr":"3446384531735984","authorId":3446384531735984,"name":"赵大侠啊","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":138095,"objectIdStr":"138095","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"给你点赞","text":"给你点赞","html":"给你点赞","likeSize":1,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"invalid","coins":0,"score":0}],"isCommentEnd":false,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/138095"}